News Formal

Hong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger

  • 📰 CNBC
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 72%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, a source told CNBC.

Prenetics is a diagnostic and genetic testing company with significant operations in Hong Kong and the U.K.

Signage for Prenetics, a Hong Kong-based biotechnology company, at the company's laboratory in Hong Kong, China, on Jan. 26, 2018.Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, according to a source close to the deal.

The transaction is expected to close by the end of this year. UBS, Citi, Credit Suisse and CICC are financial advisors on the potential de-SPAC transaction.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

What a forgettable name!

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 12. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인